Cargando…

High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector

The spike (S) protein is one of the three proteins forming the coronaviruses’ viral envelope. The S protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has a spatial structure similar to the S proteins of other mammalian coronaviruses, except for a unique receptor-binding dom...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinegubova, Maria V., Orlova, Nadezhda A., Kovnir, Sergey V., Dayanova, Lutsia K., Vorobiev, Ivan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853477/
https://www.ncbi.nlm.nih.gov/pubmed/33529230
http://dx.doi.org/10.1371/journal.pone.0242890
_version_ 1783645969219321856
author Sinegubova, Maria V.
Orlova, Nadezhda A.
Kovnir, Sergey V.
Dayanova, Lutsia K.
Vorobiev, Ivan I.
author_facet Sinegubova, Maria V.
Orlova, Nadezhda A.
Kovnir, Sergey V.
Dayanova, Lutsia K.
Vorobiev, Ivan I.
author_sort Sinegubova, Maria V.
collection PubMed
description The spike (S) protein is one of the three proteins forming the coronaviruses’ viral envelope. The S protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has a spatial structure similar to the S proteins of other mammalian coronaviruses, except for a unique receptor-binding domain (RBD), which is a significant inducer of host immune response. Recombinant SARS-CoV-2 RBD is widely used as a highly specific minimal antigen for serological tests. Correct exposure of antigenic determinants has a significant impact on the accuracy of such tests–the antigen has to be correctly folded, contain no potentially antigenic non-vertebrate glycans, and, preferably, should have a glycosylation pattern similar to the native S protein. Based on the previously developed p1.1 vector, containing the regulatory sequences of the Eukaryotic translation elongation factor 1 alpha gene (EEF1A1) from Chinese hamster, we created two expression constructs encoding SARS-CoV-2 RBD with C-terminal c-myc and polyhistidine tags. RBDv1 contained a native viral signal peptide, RBDv2 –human tPA signal peptide. We transfected a CHO DG44 cell line, selected stably transfected cells, and performed a few rounds of methotrexate-driven amplification of the genetic cassette in the genome. For the RBDv2 variant, a high-yield clonal producer cell line was obtained. We developed a simple purification scheme that consistently yielded up to 30 mg of RBD protein per liter of the simple shake flask cell culture. Purified proteins were analyzed by polyacrylamide gel electrophoresis in reducing and non-reducing conditions and gel filtration; for RBDv2 protein, the monomeric form content exceeded 90% for several series. Deglycosylation with PNGase F and mass spectrometry confirmed the presence of N-glycosylation. The antigen produced by the described technique is suitable for serological tests and subunit vaccine studies.
format Online
Article
Text
id pubmed-7853477
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-78534772021-02-09 High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector Sinegubova, Maria V. Orlova, Nadezhda A. Kovnir, Sergey V. Dayanova, Lutsia K. Vorobiev, Ivan I. PLoS One Research Article The spike (S) protein is one of the three proteins forming the coronaviruses’ viral envelope. The S protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has a spatial structure similar to the S proteins of other mammalian coronaviruses, except for a unique receptor-binding domain (RBD), which is a significant inducer of host immune response. Recombinant SARS-CoV-2 RBD is widely used as a highly specific minimal antigen for serological tests. Correct exposure of antigenic determinants has a significant impact on the accuracy of such tests–the antigen has to be correctly folded, contain no potentially antigenic non-vertebrate glycans, and, preferably, should have a glycosylation pattern similar to the native S protein. Based on the previously developed p1.1 vector, containing the regulatory sequences of the Eukaryotic translation elongation factor 1 alpha gene (EEF1A1) from Chinese hamster, we created two expression constructs encoding SARS-CoV-2 RBD with C-terminal c-myc and polyhistidine tags. RBDv1 contained a native viral signal peptide, RBDv2 –human tPA signal peptide. We transfected a CHO DG44 cell line, selected stably transfected cells, and performed a few rounds of methotrexate-driven amplification of the genetic cassette in the genome. For the RBDv2 variant, a high-yield clonal producer cell line was obtained. We developed a simple purification scheme that consistently yielded up to 30 mg of RBD protein per liter of the simple shake flask cell culture. Purified proteins were analyzed by polyacrylamide gel electrophoresis in reducing and non-reducing conditions and gel filtration; for RBDv2 protein, the monomeric form content exceeded 90% for several series. Deglycosylation with PNGase F and mass spectrometry confirmed the presence of N-glycosylation. The antigen produced by the described technique is suitable for serological tests and subunit vaccine studies. Public Library of Science 2021-02-02 /pmc/articles/PMC7853477/ /pubmed/33529230 http://dx.doi.org/10.1371/journal.pone.0242890 Text en © 2021 Sinegubova et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Sinegubova, Maria V.
Orlova, Nadezhda A.
Kovnir, Sergey V.
Dayanova, Lutsia K.
Vorobiev, Ivan I.
High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
title High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
title_full High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
title_fullStr High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
title_full_unstemmed High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
title_short High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
title_sort high-level expression of the monomeric sars-cov-2 s protein rbd 320-537 in stably transfected cho cells by the eef1a1-based plasmid vector
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853477/
https://www.ncbi.nlm.nih.gov/pubmed/33529230
http://dx.doi.org/10.1371/journal.pone.0242890
work_keys_str_mv AT sinegubovamariav highlevelexpressionofthemonomericsarscov2sproteinrbd320537instablytransfectedchocellsbytheeef1a1basedplasmidvector
AT orlovanadezhdaa highlevelexpressionofthemonomericsarscov2sproteinrbd320537instablytransfectedchocellsbytheeef1a1basedplasmidvector
AT kovnirsergeyv highlevelexpressionofthemonomericsarscov2sproteinrbd320537instablytransfectedchocellsbytheeef1a1basedplasmidvector
AT dayanovalutsiak highlevelexpressionofthemonomericsarscov2sproteinrbd320537instablytransfectedchocellsbytheeef1a1basedplasmidvector
AT vorobievivani highlevelexpressionofthemonomericsarscov2sproteinrbd320537instablytransfectedchocellsbytheeef1a1basedplasmidvector